nodes	percent_of_prediction	percent_of_DWPC	metapath
Indomethacin—CXCL8—psoriasis	0.156	0.591	CbGaD
Indomethacin—migraine—Prednisone—psoriasis	0.134	0.508	CpDpCtD
Indomethacin—osteoarthritis—Prednisone—psoriasis	0.13	0.492	CpDpCtD
Indomethacin—PPARG—psoriasis	0.108	0.409	CbGaD
Indomethacin—UGT1A9—Mycophenolic acid—psoriasis	0.0232	0.0697	CbGbCtD
Indomethacin—UGT2B7—Mycophenolic acid—psoriasis	0.0219	0.0659	CbGbCtD
Indomethacin—CES1—Mycophenolate mofetil—psoriasis	0.0213	0.0641	CbGbCtD
Indomethacin—ABCC11—Methotrexate—psoriasis	0.0206	0.0619	CbGbCtD
Indomethacin—SLC10A1—Cyclosporine—psoriasis	0.0193	0.0581	CbGbCtD
Indomethacin—UGT1A1—Mycophenolic acid—psoriasis	0.019	0.057	CbGbCtD
Indomethacin—UGT1A9—Mycophenolate mofetil—psoriasis	0.013	0.0389	CbGbCtD
Indomethacin—UGT2B7—Mycophenolate mofetil—psoriasis	0.0123	0.0368	CbGbCtD
Indomethacin—ABCC3—Cyclosporine—psoriasis	0.0107	0.0323	CbGbCtD
Indomethacin—UGT1A1—Mycophenolate mofetil—psoriasis	0.0106	0.0318	CbGbCtD
Indomethacin—ALB—Acitretin—psoriasis	0.00858	0.0258	CbGbCtD
Indomethacin—SLCO1B1—Mycophenolate mofetil—psoriasis	0.00733	0.022	CbGbCtD
Indomethacin—ABCC1—Cyclosporine—psoriasis	0.0066	0.0198	CbGbCtD
Indomethacin—SLCO1A2—Prednisolone—psoriasis	0.00658	0.0198	CbGbCtD
Indomethacin—ABCC2—Mycophenolate mofetil—psoriasis	0.00645	0.0194	CbGbCtD
Indomethacin—PTGS2—Triamcinolone—psoriasis	0.00637	0.0191	CbGbCtD
Indomethacin—SLCO1A2—Hydrocortisone—psoriasis	0.00624	0.0188	CbGbCtD
Indomethacin—SLCO1A2—Prednisone—psoriasis	0.00622	0.0187	CbGbCtD
Indomethacin—SLCO1A2—Cyclosporine—psoriasis	0.00589	0.0177	CbGbCtD
Indomethacin—PLA2G2A—synovial fluid—psoriasis	0.00577	0.266	CbGeAlD
Indomethacin—ABCC3—Methotrexate—psoriasis	0.00569	0.0171	CbGbCtD
Indomethacin—SLCO1B1—Cyclosporine—psoriasis	0.00556	0.0167	CbGbCtD
Indomethacin—PTGS2—Betamethasone—psoriasis	0.00546	0.0164	CbGbCtD
Indomethacin—ABCC2—Cyclosporine—psoriasis	0.00488	0.0147	CbGbCtD
Indomethacin—SLC22A11—Methotrexate—psoriasis	0.00467	0.014	CbGbCtD
Indomethacin—SLC22A7—Methotrexate—psoriasis	0.00445	0.0134	CbGbCtD
Indomethacin—ABCC4—Methotrexate—psoriasis	0.00435	0.0131	CbGbCtD
Indomethacin—ABCC6—dermis—psoriasis	0.00428	0.197	CbGeAlD
Indomethacin—ALB—Mycophenolate mofetil—psoriasis	0.00402	0.0121	CbGbCtD
Indomethacin—SLCO1A2—Dexamethasone—psoriasis	0.00388	0.0117	CbGbCtD
Indomethacin—SLC22A6—Cyclosporine—psoriasis	0.00357	0.0107	CbGbCtD
Indomethacin—ABCC1—Methotrexate—psoriasis	0.00349	0.0105	CbGbCtD
Indomethacin—ABCC2—Dexamethasone—psoriasis	0.00322	0.00967	CbGbCtD
Indomethacin—ALB—Prednisone—psoriasis	0.00321	0.00965	CbGbCtD
Indomethacin—PTGS2—Dexamethasone—psoriasis	0.00318	0.00955	CbGbCtD
Indomethacin—SLCO1A2—Methotrexate—psoriasis	0.00312	0.00937	CbGbCtD
Indomethacin—CYP2C19—Cholecalciferol—psoriasis	0.003	0.00903	CbGbCtD
Indomethacin—SLCO1B1—Methotrexate—psoriasis	0.00294	0.00884	CbGbCtD
Indomethacin—SLC22A8—Methotrexate—psoriasis	0.00272	0.00816	CbGbCtD
Indomethacin—ABCC2—Methotrexate—psoriasis	0.00258	0.00777	CbGbCtD
Indomethacin—CYP2C9—Cholecalciferol—psoriasis	0.0025	0.0075	CbGbCtD
Indomethacin—PPARG—dermis—psoriasis	0.00222	0.102	CbGeAlD
Indomethacin—ABCB1—Mycophenolate mofetil—psoriasis	0.0021	0.00631	CbGbCtD
Indomethacin—CYP2C19—Prednisone—psoriasis	0.00208	0.00626	CbGbCtD
Indomethacin—CYP2C19—Cyclosporine—psoriasis	0.00197	0.00593	CbGbCtD
Indomethacin—SLC22A6—Methotrexate—psoriasis	0.00189	0.00568	CbGbCtD
Indomethacin—ABCB1—Betamethasone—psoriasis	0.0018	0.00542	CbGbCtD
Indomethacin—ABCB1—Prednisolone—psoriasis	0.00178	0.00535	CbGbCtD
Indomethacin—ABCB1—Hydrocortisone—psoriasis	0.00169	0.00507	CbGbCtD
Indomethacin—ABCB1—Prednisone—psoriasis	0.00168	0.00505	CbGbCtD
Indomethacin—CYP2C9—Cyclosporine—psoriasis	0.00164	0.00493	CbGbCtD
Indomethacin—ALB—Methotrexate—psoriasis	0.00161	0.00484	CbGbCtD
Indomethacin—ABCB1—Cyclosporine—psoriasis	0.00159	0.00479	CbGbCtD
Indomethacin—CYP2C19—Dexamethasone—psoriasis	0.0013	0.00391	CbGbCtD
Indomethacin—PTGDR2—tendon—psoriasis	0.00113	0.0519	CbGeAlD
Indomethacin—CYP2C9—Dexamethasone—psoriasis	0.00108	0.00325	CbGbCtD
Indomethacin—ABCB1—Dexamethasone—psoriasis	0.00105	0.00315	CbGbCtD
Indomethacin—PTGS2—skeletal joint—psoriasis	0.00098	0.0452	CbGeAlD
Indomethacin—ABCB1—Methotrexate—psoriasis	0.000843	0.00253	CbGbCtD
Indomethacin—Tolmetin—CXCL8—psoriasis	0.00078	0.638	CrCbGaD
Indomethacin—PTGR2—tendon—psoriasis	0.000747	0.0344	CbGeAlD
Indomethacin—PTGS2—synovial membrane of synovial joint—psoriasis	0.000744	0.0343	CbGeAlD
Indomethacin—PPARG—endothelium—psoriasis	0.000678	0.0313	CbGeAlD
Indomethacin—GLO1—skin of body—psoriasis	0.000606	0.0279	CbGeAlD
Indomethacin—PPARA—skin of body—psoriasis	0.000526	0.0243	CbGeAlD
Indomethacin—PTGS2—skin epidermis—psoriasis	0.000477	0.022	CbGeAlD
Indomethacin—GLO1—tendon—psoriasis	0.000461	0.0213	CbGeAlD
Indomethacin—Bezafibrate—PPARG—psoriasis	0.000444	0.362	CrCbGaD
Indomethacin—PLA2G2A—tendon—psoriasis	0.000429	0.0198	CbGeAlD
Indomethacin—PTGS1—endothelium—psoriasis	0.000362	0.0167	CbGeAlD
Indomethacin—PTGS2—endothelium—psoriasis	0.000346	0.016	CbGeAlD
Indomethacin—AKR1C3—tendon—psoriasis	0.000333	0.0153	CbGeAlD
Indomethacin—PPARG—skin of body—psoriasis	0.000289	0.0133	CbGeAlD
Indomethacin—PTGS2—Fluocinonide—Clobetasol propionate—psoriasis	0.000241	0.157	CbGdCrCtD
Indomethacin—PPARG—tendon—psoriasis	0.00022	0.0102	CbGeAlD
Indomethacin—ABCC4—tendon—psoriasis	0.0002	0.00922	CbGeAlD
Indomethacin—ABCC2—tendon—psoriasis	0.000194	0.00893	CbGeAlD
Indomethacin—PTGS2—Fluocinonide—Beclomethasone—psoriasis	0.000193	0.126	CbGdCrCtD
Indomethacin—PTGS2—Fluocinonide—Fluocinolone Acetonide—psoriasis	0.000187	0.122	CbGdCrCtD
Indomethacin—ABCC1—tendon—psoriasis	0.000171	0.00786	CbGeAlD
Indomethacin—PTGS1—skin of body—psoriasis	0.000155	0.00713	CbGeAlD
Indomethacin—PTGS2—skin of body—psoriasis	0.000148	0.00682	CbGeAlD
Indomethacin—PTGS2—Fluticasone Propionate—Clobetasol propionate—psoriasis	0.000145	0.0949	CbGdCrCtD
Indomethacin—PTGS1—tendon—psoriasis	0.000118	0.00543	CbGeAlD
Indomethacin—PTGS2—Fluticasone Propionate—Beclomethasone—psoriasis	0.000116	0.076	CbGdCrCtD
Indomethacin—PTGS2—Fluticasone Propionate—Fluocinonide—psoriasis	0.000116	0.076	CbGdCrCtD
Indomethacin—PTGS2—Fluticasone Propionate—Fluocinolone Acetonide—psoriasis	0.000113	0.0738	CbGdCrCtD
Indomethacin—PTGS2—tendon—psoriasis	0.000113	0.00519	CbGeAlD
Indomethacin—PTGS2—Fluocinonide—Dexamethasone—psoriasis	8.79e-05	0.0574	CbGdCrCtD
Indomethacin—PTGS2—Fluocinonide—Betamethasone—psoriasis	8.79e-05	0.0574	CbGdCrCtD
Indomethacin—PTGS2—Fluocinonide—Triamcinolone—psoriasis	8.59e-05	0.0561	CbGdCrCtD
Indomethacin—PTGS2—Fluticasone Propionate—Dexamethasone—psoriasis	5.3e-05	0.0346	CbGdCrCtD
Indomethacin—PTGS2—Fluticasone Propionate—Betamethasone—psoriasis	5.3e-05	0.0346	CbGdCrCtD
Indomethacin—PTGS2—Fluticasone Propionate—Triamcinolone—psoriasis	5.18e-05	0.0338	CbGdCrCtD
Indomethacin—Syncope—Dexamethasone—psoriasis	3.28e-05	0.000402	CcSEcCtD
Indomethacin—Constipation—Mycophenolate mofetil—psoriasis	3.28e-05	0.000402	CcSEcCtD
Indomethacin—Pain—Mycophenolate mofetil—psoriasis	3.28e-05	0.000402	CcSEcCtD
Indomethacin—Arrhythmia—Prednisone—psoriasis	3.26e-05	0.000401	CcSEcCtD
Indomethacin—Sweating—Methotrexate—psoriasis	3.26e-05	0.000401	CcSEcCtD
Indomethacin—Hypotension—Hydrocortisone—psoriasis	3.26e-05	0.000401	CcSEcCtD
Indomethacin—Haematuria—Methotrexate—psoriasis	3.24e-05	0.000399	CcSEcCtD
Indomethacin—Feeling abnormal—Cyclosporine—psoriasis	3.24e-05	0.000398	CcSEcCtD
Indomethacin—Shock—Triamcinolone—psoriasis	3.23e-05	0.000397	CcSEcCtD
Indomethacin—Insomnia—Prednisolone—psoriasis	3.23e-05	0.000397	CcSEcCtD
Indomethacin—Alopecia—Prednisone—psoriasis	3.23e-05	0.000397	CcSEcCtD
Indomethacin—Gastrointestinal pain—Cyclosporine—psoriasis	3.21e-05	0.000394	CcSEcCtD
Indomethacin—Loss of consciousness—Dexamethasone—psoriasis	3.21e-05	0.000394	CcSEcCtD
Indomethacin—Loss of consciousness—Betamethasone—psoriasis	3.21e-05	0.000394	CcSEcCtD
Indomethacin—Dizziness—Mycophenolic acid—psoriasis	3.21e-05	0.000394	CcSEcCtD
Indomethacin—Epistaxis—Methotrexate—psoriasis	3.21e-05	0.000394	CcSEcCtD
Indomethacin—Paraesthesia—Prednisolone—psoriasis	3.21e-05	0.000394	CcSEcCtD
Indomethacin—Tachycardia—Triamcinolone—psoriasis	3.21e-05	0.000394	CcSEcCtD
Indomethacin—Erythema—Prednisone—psoriasis	3.18e-05	0.000391	CcSEcCtD
Indomethacin—Hyperhidrosis—Triamcinolone—psoriasis	3.18e-05	0.00039	CcSEcCtD
Indomethacin—Agranulocytosis—Methotrexate—psoriasis	3.17e-05	0.00039	CcSEcCtD
Indomethacin—Convulsion—Dexamethasone—psoriasis	3.17e-05	0.000389	CcSEcCtD
Indomethacin—Convulsion—Betamethasone—psoriasis	3.17e-05	0.000389	CcSEcCtD
Indomethacin—Feeling abnormal—Mycophenolate mofetil—psoriasis	3.16e-05	0.000388	CcSEcCtD
Indomethacin—Insomnia—Hydrocortisone—psoriasis	3.16e-05	0.000388	CcSEcCtD
Indomethacin—Hypertension—Dexamethasone—psoriasis	3.15e-05	0.000387	CcSEcCtD
Indomethacin—Hypertension—Betamethasone—psoriasis	3.15e-05	0.000387	CcSEcCtD
Indomethacin—Paraesthesia—Hydrocortisone—psoriasis	3.13e-05	0.000385	CcSEcCtD
Indomethacin—Gastrointestinal pain—Mycophenolate mofetil—psoriasis	3.13e-05	0.000385	CcSEcCtD
Indomethacin—Urticaria—Cyclosporine—psoriasis	3.12e-05	0.000383	CcSEcCtD
Indomethacin—Abdominal pain—Cyclosporine—psoriasis	3.1e-05	0.000381	CcSEcCtD
Indomethacin—Body temperature increased—Cyclosporine—psoriasis	3.1e-05	0.000381	CcSEcCtD
Indomethacin—Anxiety—Dexamethasone—psoriasis	3.1e-05	0.000381	CcSEcCtD
Indomethacin—Anxiety—Betamethasone—psoriasis	3.1e-05	0.000381	CcSEcCtD
Indomethacin—Vomiting—Mycophenolic acid—psoriasis	3.09e-05	0.000379	CcSEcCtD
Indomethacin—Discomfort—Dexamethasone—psoriasis	3.07e-05	0.000378	CcSEcCtD
Indomethacin—Discomfort—Betamethasone—psoriasis	3.07e-05	0.000378	CcSEcCtD
Indomethacin—Dyspepsia—Hydrocortisone—psoriasis	3.07e-05	0.000377	CcSEcCtD
Indomethacin—Haemoglobin—Methotrexate—psoriasis	3.07e-05	0.000377	CcSEcCtD
Indomethacin—Rash—Mycophenolic acid—psoriasis	3.06e-05	0.000376	CcSEcCtD
Indomethacin—Dermatitis—Mycophenolic acid—psoriasis	3.06e-05	0.000376	CcSEcCtD
Indomethacin—Pain—Prednisolone—psoriasis	3.06e-05	0.000375	CcSEcCtD
Indomethacin—Hepatitis—Methotrexate—psoriasis	3.05e-05	0.000375	CcSEcCtD
Indomethacin—Haemorrhage—Methotrexate—psoriasis	3.05e-05	0.000375	CcSEcCtD
Indomethacin—Urticaria—Mycophenolate mofetil—psoriasis	3.04e-05	0.000374	CcSEcCtD
Indomethacin—Headache—Mycophenolic acid—psoriasis	3.04e-05	0.000374	CcSEcCtD
Indomethacin—Decreased appetite—Hydrocortisone—psoriasis	3.03e-05	0.000373	CcSEcCtD
Indomethacin—Abdominal pain—Mycophenolate mofetil—psoriasis	3.03e-05	0.000372	CcSEcCtD
Indomethacin—Body temperature increased—Mycophenolate mofetil—psoriasis	3.03e-05	0.000372	CcSEcCtD
Indomethacin—Fatigue—Hydrocortisone—psoriasis	3.01e-05	0.00037	CcSEcCtD
Indomethacin—Vision blurred—Prednisone—psoriasis	3e-05	0.000368	CcSEcCtD
Indomethacin—Pain—Hydrocortisone—psoriasis	2.98e-05	0.000367	CcSEcCtD
Indomethacin—Anaphylactic shock—Betamethasone—psoriasis	2.98e-05	0.000366	CcSEcCtD
Indomethacin—Oedema—Betamethasone—psoriasis	2.98e-05	0.000366	CcSEcCtD
Indomethacin—Anaphylactic shock—Dexamethasone—psoriasis	2.98e-05	0.000366	CcSEcCtD
Indomethacin—Oedema—Dexamethasone—psoriasis	2.98e-05	0.000366	CcSEcCtD
Indomethacin—Insomnia—Triamcinolone—psoriasis	2.97e-05	0.000365	CcSEcCtD
Indomethacin—Ill-defined disorder—Prednisone—psoriasis	2.95e-05	0.000363	CcSEcCtD
Indomethacin—Paraesthesia—Triamcinolone—psoriasis	2.95e-05	0.000362	CcSEcCtD
Indomethacin—Feeling abnormal—Prednisolone—psoriasis	2.94e-05	0.000362	CcSEcCtD
Indomethacin—Anaemia—Prednisone—psoriasis	2.94e-05	0.000361	CcSEcCtD
Indomethacin—Shock—Dexamethasone—psoriasis	2.93e-05	0.00036	CcSEcCtD
Indomethacin—Shock—Betamethasone—psoriasis	2.93e-05	0.00036	CcSEcCtD
Indomethacin—Dyspnoea—Triamcinolone—psoriasis	2.93e-05	0.00036	CcSEcCtD
Indomethacin—Thrombocytopenia—Dexamethasone—psoriasis	2.92e-05	0.000359	CcSEcCtD
Indomethacin—Thrombocytopenia—Betamethasone—psoriasis	2.92e-05	0.000359	CcSEcCtD
Indomethacin—Tachycardia—Betamethasone—psoriasis	2.91e-05	0.000357	CcSEcCtD
Indomethacin—Tachycardia—Dexamethasone—psoriasis	2.91e-05	0.000357	CcSEcCtD
Indomethacin—Angioedema—Prednisone—psoriasis	2.91e-05	0.000357	CcSEcCtD
Indomethacin—Hypersensitivity—Cyclosporine—psoriasis	2.89e-05	0.000355	CcSEcCtD
Indomethacin—Dyspepsia—Triamcinolone—psoriasis	2.89e-05	0.000355	CcSEcCtD
Indomethacin—Erythema multiforme—Methotrexate—psoriasis	2.89e-05	0.000355	CcSEcCtD
Indomethacin—Nausea—Mycophenolic acid—psoriasis	2.88e-05	0.000354	CcSEcCtD
Indomethacin—Hyperhidrosis—Dexamethasone—psoriasis	2.88e-05	0.000354	CcSEcCtD
Indomethacin—Hyperhidrosis—Betamethasone—psoriasis	2.88e-05	0.000354	CcSEcCtD
Indomethacin—Feeling abnormal—Hydrocortisone—psoriasis	2.88e-05	0.000353	CcSEcCtD
Indomethacin—Malaise—Prednisone—psoriasis	2.87e-05	0.000352	CcSEcCtD
Indomethacin—Vertigo—Prednisone—psoriasis	2.86e-05	0.000351	CcSEcCtD
Indomethacin—Gastrointestinal pain—Hydrocortisone—psoriasis	2.85e-05	0.000351	CcSEcCtD
Indomethacin—Syncope—Prednisone—psoriasis	2.85e-05	0.00035	CcSEcCtD
Indomethacin—Tinnitus—Methotrexate—psoriasis	2.85e-05	0.00035	CcSEcCtD
Indomethacin—Anorexia—Betamethasone—psoriasis	2.84e-05	0.000349	CcSEcCtD
Indomethacin—Anorexia—Dexamethasone—psoriasis	2.84e-05	0.000349	CcSEcCtD
Indomethacin—Urticaria—Prednisolone—psoriasis	2.84e-05	0.000349	CcSEcCtD
Indomethacin—Fatigue—Triamcinolone—psoriasis	2.83e-05	0.000348	CcSEcCtD
Indomethacin—Hypersensitivity—Mycophenolate mofetil—psoriasis	2.82e-05	0.000347	CcSEcCtD
Indomethacin—Asthenia—Cyclosporine—psoriasis	2.82e-05	0.000346	CcSEcCtD
Indomethacin—Pain—Triamcinolone—psoriasis	2.81e-05	0.000345	CcSEcCtD
Indomethacin—Loss of consciousness—Prednisone—psoriasis	2.8e-05	0.000344	CcSEcCtD
Indomethacin—Hypotension—Dexamethasone—psoriasis	2.79e-05	0.000342	CcSEcCtD
Indomethacin—Hypotension—Betamethasone—psoriasis	2.79e-05	0.000342	CcSEcCtD
Indomethacin—Pruritus—Cyclosporine—psoriasis	2.78e-05	0.000341	CcSEcCtD
Indomethacin—Urticaria—Hydrocortisone—psoriasis	2.77e-05	0.000341	CcSEcCtD
Indomethacin—Abdominal pain—Hydrocortisone—psoriasis	2.76e-05	0.000339	CcSEcCtD
Indomethacin—Body temperature increased—Hydrocortisone—psoriasis	2.76e-05	0.000339	CcSEcCtD
Indomethacin—Convulsion—Prednisone—psoriasis	2.76e-05	0.000339	CcSEcCtD
Indomethacin—Asthenia—Mycophenolate mofetil—psoriasis	2.75e-05	0.000338	CcSEcCtD
Indomethacin—Hypertension—Prednisone—psoriasis	2.75e-05	0.000337	CcSEcCtD
Indomethacin—Pruritus—Mycophenolate mofetil—psoriasis	2.71e-05	0.000333	CcSEcCtD
Indomethacin—Feeling abnormal—Triamcinolone—psoriasis	2.71e-05	0.000333	CcSEcCtD
Indomethacin—Anxiety—Prednisone—psoriasis	2.7e-05	0.000332	CcSEcCtD
Indomethacin—Alopecia—Methotrexate—psoriasis	2.7e-05	0.000332	CcSEcCtD
Indomethacin—Insomnia—Dexamethasone—psoriasis	2.7e-05	0.000331	CcSEcCtD
Indomethacin—Insomnia—Betamethasone—psoriasis	2.7e-05	0.000331	CcSEcCtD
Indomethacin—Diarrhoea—Cyclosporine—psoriasis	2.69e-05	0.00033	CcSEcCtD
Indomethacin—Paraesthesia—Betamethasone—psoriasis	2.68e-05	0.000329	CcSEcCtD
Indomethacin—Paraesthesia—Dexamethasone—psoriasis	2.68e-05	0.000329	CcSEcCtD
Indomethacin—Discomfort—Prednisone—psoriasis	2.68e-05	0.000329	CcSEcCtD
Indomethacin—Erythema—Methotrexate—psoriasis	2.66e-05	0.000327	CcSEcCtD
Indomethacin—Hypersensitivity—Prednisolone—psoriasis	2.63e-05	0.000323	CcSEcCtD
Indomethacin—Dyspepsia—Betamethasone—psoriasis	2.62e-05	0.000322	CcSEcCtD
Indomethacin—Dyspepsia—Dexamethasone—psoriasis	2.62e-05	0.000322	CcSEcCtD
Indomethacin—Diarrhoea—Mycophenolate mofetil—psoriasis	2.62e-05	0.000322	CcSEcCtD
Indomethacin—Urticaria—Triamcinolone—psoriasis	2.61e-05	0.000321	CcSEcCtD
Indomethacin—Body temperature increased—Triamcinolone—psoriasis	2.6e-05	0.000319	CcSEcCtD
Indomethacin—Dizziness—Cyclosporine—psoriasis	2.6e-05	0.000319	CcSEcCtD
Indomethacin—Oedema—Prednisone—psoriasis	2.6e-05	0.000319	CcSEcCtD
Indomethacin—Anaphylactic shock—Prednisone—psoriasis	2.6e-05	0.000319	CcSEcCtD
Indomethacin—Decreased appetite—Dexamethasone—psoriasis	2.59e-05	0.000318	CcSEcCtD
Indomethacin—Decreased appetite—Betamethasone—psoriasis	2.59e-05	0.000318	CcSEcCtD
Indomethacin—Hypersensitivity—Hydrocortisone—psoriasis	2.57e-05	0.000316	CcSEcCtD
Indomethacin—Fatigue—Dexamethasone—psoriasis	2.57e-05	0.000316	CcSEcCtD
Indomethacin—Fatigue—Betamethasone—psoriasis	2.57e-05	0.000316	CcSEcCtD
Indomethacin—Shock—Prednisone—psoriasis	2.55e-05	0.000314	CcSEcCtD
Indomethacin—Pain—Dexamethasone—psoriasis	2.55e-05	0.000313	CcSEcCtD
Indomethacin—Pain—Betamethasone—psoriasis	2.55e-05	0.000313	CcSEcCtD
Indomethacin—Tachycardia—Prednisone—psoriasis	2.53e-05	0.000311	CcSEcCtD
Indomethacin—Dizziness—Mycophenolate mofetil—psoriasis	2.53e-05	0.000311	CcSEcCtD
Indomethacin—Hyperhidrosis—Prednisone—psoriasis	2.51e-05	0.000308	CcSEcCtD
Indomethacin—Vision blurred—Methotrexate—psoriasis	2.51e-05	0.000308	CcSEcCtD
Indomethacin—Asthenia—Hydrocortisone—psoriasis	2.5e-05	0.000308	CcSEcCtD
Indomethacin—Vomiting—Cyclosporine—psoriasis	2.5e-05	0.000307	CcSEcCtD
Indomethacin—Rash—Cyclosporine—psoriasis	2.48e-05	0.000304	CcSEcCtD
Indomethacin—Anorexia—Prednisone—psoriasis	2.47e-05	0.000304	CcSEcCtD
Indomethacin—Dermatitis—Cyclosporine—psoriasis	2.47e-05	0.000304	CcSEcCtD
Indomethacin—Pruritus—Hydrocortisone—psoriasis	2.47e-05	0.000303	CcSEcCtD
Indomethacin—Ill-defined disorder—Methotrexate—psoriasis	2.47e-05	0.000303	CcSEcCtD
Indomethacin—Headache—Cyclosporine—psoriasis	2.46e-05	0.000302	CcSEcCtD
Indomethacin—Anaemia—Methotrexate—psoriasis	2.46e-05	0.000302	CcSEcCtD
Indomethacin—Feeling abnormal—Betamethasone—psoriasis	2.46e-05	0.000302	CcSEcCtD
Indomethacin—Feeling abnormal—Dexamethasone—psoriasis	2.46e-05	0.000302	CcSEcCtD
Indomethacin—Gastrointestinal pain—Dexamethasone—psoriasis	2.44e-05	0.0003	CcSEcCtD
Indomethacin—Gastrointestinal pain—Betamethasone—psoriasis	2.44e-05	0.0003	CcSEcCtD
Indomethacin—Vomiting—Mycophenolate mofetil—psoriasis	2.44e-05	0.000299	CcSEcCtD
Indomethacin—Hypersensitivity—Triamcinolone—psoriasis	2.42e-05	0.000297	CcSEcCtD
Indomethacin—Rash—Mycophenolate mofetil—psoriasis	2.42e-05	0.000297	CcSEcCtD
Indomethacin—Dermatitis—Mycophenolate mofetil—psoriasis	2.41e-05	0.000296	CcSEcCtD
Indomethacin—Headache—Mycophenolate mofetil—psoriasis	2.4e-05	0.000295	CcSEcCtD
Indomethacin—Malaise—Methotrexate—psoriasis	2.4e-05	0.000295	CcSEcCtD
Indomethacin—Vertigo—Methotrexate—psoriasis	2.39e-05	0.000293	CcSEcCtD
Indomethacin—Diarrhoea—Hydrocortisone—psoriasis	2.39e-05	0.000293	CcSEcCtD
Indomethacin—Leukopenia—Methotrexate—psoriasis	2.38e-05	0.000292	CcSEcCtD
Indomethacin—Urticaria—Betamethasone—psoriasis	2.37e-05	0.000291	CcSEcCtD
Indomethacin—Urticaria—Dexamethasone—psoriasis	2.37e-05	0.000291	CcSEcCtD
Indomethacin—Dizziness—Prednisolone—psoriasis	2.36e-05	0.00029	CcSEcCtD
Indomethacin—Asthenia—Triamcinolone—psoriasis	2.36e-05	0.00029	CcSEcCtD
Indomethacin—Abdominal pain—Betamethasone—psoriasis	2.36e-05	0.00029	CcSEcCtD
Indomethacin—Abdominal pain—Dexamethasone—psoriasis	2.36e-05	0.00029	CcSEcCtD
Indomethacin—Body temperature increased—Betamethasone—psoriasis	2.36e-05	0.00029	CcSEcCtD
Indomethacin—Body temperature increased—Dexamethasone—psoriasis	2.36e-05	0.00029	CcSEcCtD
Indomethacin—Insomnia—Prednisone—psoriasis	2.35e-05	0.000289	CcSEcCtD
Indomethacin—Nausea—Cyclosporine—psoriasis	2.33e-05	0.000287	CcSEcCtD
Indomethacin—Paraesthesia—Prednisone—psoriasis	2.33e-05	0.000286	CcSEcCtD
Indomethacin—Pruritus—Triamcinolone—psoriasis	2.32e-05	0.000286	CcSEcCtD
Indomethacin—Dizziness—Hydrocortisone—psoriasis	2.31e-05	0.000283	CcSEcCtD
Indomethacin—Convulsion—Methotrexate—psoriasis	2.3e-05	0.000283	CcSEcCtD
Indomethacin—Dyspepsia—Prednisone—psoriasis	2.29e-05	0.000281	CcSEcCtD
Indomethacin—Nausea—Mycophenolate mofetil—psoriasis	2.28e-05	0.00028	CcSEcCtD
Indomethacin—Chest pain—Methotrexate—psoriasis	2.26e-05	0.000278	CcSEcCtD
Indomethacin—Decreased appetite—Prednisone—psoriasis	2.26e-05	0.000277	CcSEcCtD
Indomethacin—Rash—Prednisolone—psoriasis	2.25e-05	0.000277	CcSEcCtD
Indomethacin—Dermatitis—Prednisolone—psoriasis	2.25e-05	0.000277	CcSEcCtD
Indomethacin—Fatigue—Prednisone—psoriasis	2.24e-05	0.000275	CcSEcCtD
Indomethacin—Headache—Prednisolone—psoriasis	2.24e-05	0.000275	CcSEcCtD
Indomethacin—Discomfort—Methotrexate—psoriasis	2.24e-05	0.000275	CcSEcCtD
Indomethacin—Constipation—Prednisone—psoriasis	2.22e-05	0.000273	CcSEcCtD
Indomethacin—Vomiting—Hydrocortisone—psoriasis	2.22e-05	0.000273	CcSEcCtD
Indomethacin—Rash—Hydrocortisone—psoriasis	2.2e-05	0.00027	CcSEcCtD
Indomethacin—Dermatitis—Hydrocortisone—psoriasis	2.2e-05	0.00027	CcSEcCtD
Indomethacin—Confusional state—Methotrexate—psoriasis	2.19e-05	0.000269	CcSEcCtD
Indomethacin—Headache—Hydrocortisone—psoriasis	2.19e-05	0.000269	CcSEcCtD
Indomethacin—Dizziness—Triamcinolone—psoriasis	2.17e-05	0.000267	CcSEcCtD
Indomethacin—Anaphylactic shock—Methotrexate—psoriasis	2.17e-05	0.000267	CcSEcCtD
Indomethacin—Feeling abnormal—Prednisone—psoriasis	2.14e-05	0.000263	CcSEcCtD
Indomethacin—Asthenia—Dexamethasone—psoriasis	2.14e-05	0.000263	CcSEcCtD
Indomethacin—Asthenia—Betamethasone—psoriasis	2.14e-05	0.000263	CcSEcCtD
Indomethacin—Thrombocytopenia—Methotrexate—psoriasis	2.12e-05	0.000261	CcSEcCtD
Indomethacin—Gastrointestinal pain—Prednisone—psoriasis	2.12e-05	0.000261	CcSEcCtD
Indomethacin—Nausea—Prednisolone—psoriasis	2.12e-05	0.000261	CcSEcCtD
Indomethacin—Pruritus—Betamethasone—psoriasis	2.11e-05	0.000259	CcSEcCtD
Indomethacin—Pruritus—Dexamethasone—psoriasis	2.11e-05	0.000259	CcSEcCtD
Indomethacin—Hyperhidrosis—Methotrexate—psoriasis	2.1e-05	0.000258	CcSEcCtD
Indomethacin—Vomiting—Triamcinolone—psoriasis	2.09e-05	0.000257	CcSEcCtD
Indomethacin—Nausea—Hydrocortisone—psoriasis	2.07e-05	0.000255	CcSEcCtD
Indomethacin—Rash—Triamcinolone—psoriasis	2.07e-05	0.000255	CcSEcCtD
Indomethacin—Dermatitis—Triamcinolone—psoriasis	2.07e-05	0.000254	CcSEcCtD
Indomethacin—Anorexia—Methotrexate—psoriasis	2.07e-05	0.000254	CcSEcCtD
Indomethacin—Urticaria—Prednisone—psoriasis	2.06e-05	0.000253	CcSEcCtD
Indomethacin—Headache—Triamcinolone—psoriasis	2.06e-05	0.000253	CcSEcCtD
Indomethacin—Abdominal pain—Prednisone—psoriasis	2.05e-05	0.000252	CcSEcCtD
Indomethacin—Body temperature increased—Prednisone—psoriasis	2.05e-05	0.000252	CcSEcCtD
Indomethacin—Diarrhoea—Dexamethasone—psoriasis	2.04e-05	0.000251	CcSEcCtD
Indomethacin—Diarrhoea—Betamethasone—psoriasis	2.04e-05	0.000251	CcSEcCtD
Indomethacin—Hypotension—Methotrexate—psoriasis	2.03e-05	0.000249	CcSEcCtD
Indomethacin—Dizziness—Betamethasone—psoriasis	1.97e-05	0.000242	CcSEcCtD
Indomethacin—Dizziness—Dexamethasone—psoriasis	1.97e-05	0.000242	CcSEcCtD
Indomethacin—Insomnia—Methotrexate—psoriasis	1.96e-05	0.000241	CcSEcCtD
Indomethacin—Nausea—Triamcinolone—psoriasis	1.95e-05	0.00024	CcSEcCtD
Indomethacin—Paraesthesia—Methotrexate—psoriasis	1.95e-05	0.000239	CcSEcCtD
Indomethacin—Dyspnoea—Methotrexate—psoriasis	1.93e-05	0.000238	CcSEcCtD
Indomethacin—Somnolence—Methotrexate—psoriasis	1.93e-05	0.000237	CcSEcCtD
Indomethacin—Hypersensitivity—Prednisone—psoriasis	1.91e-05	0.000235	CcSEcCtD
Indomethacin—Dyspepsia—Methotrexate—psoriasis	1.91e-05	0.000235	CcSEcCtD
Indomethacin—Vomiting—Dexamethasone—psoriasis	1.9e-05	0.000233	CcSEcCtD
Indomethacin—Vomiting—Betamethasone—psoriasis	1.9e-05	0.000233	CcSEcCtD
Indomethacin—Decreased appetite—Methotrexate—psoriasis	1.89e-05	0.000232	CcSEcCtD
Indomethacin—Rash—Dexamethasone—psoriasis	1.88e-05	0.000231	CcSEcCtD
Indomethacin—Rash—Betamethasone—psoriasis	1.88e-05	0.000231	CcSEcCtD
Indomethacin—Dermatitis—Betamethasone—psoriasis	1.88e-05	0.000231	CcSEcCtD
Indomethacin—Dermatitis—Dexamethasone—psoriasis	1.88e-05	0.000231	CcSEcCtD
Indomethacin—Fatigue—Methotrexate—psoriasis	1.87e-05	0.00023	CcSEcCtD
Indomethacin—Headache—Betamethasone—psoriasis	1.87e-05	0.000229	CcSEcCtD
Indomethacin—Headache—Dexamethasone—psoriasis	1.87e-05	0.000229	CcSEcCtD
Indomethacin—Asthenia—Prednisone—psoriasis	1.86e-05	0.000229	CcSEcCtD
Indomethacin—Pain—Methotrexate—psoriasis	1.86e-05	0.000228	CcSEcCtD
Indomethacin—Pruritus—Prednisone—psoriasis	1.84e-05	0.000226	CcSEcCtD
Indomethacin—Feeling abnormal—Methotrexate—psoriasis	1.79e-05	0.00022	CcSEcCtD
Indomethacin—Diarrhoea—Prednisone—psoriasis	1.78e-05	0.000218	CcSEcCtD
Indomethacin—Gastrointestinal pain—Methotrexate—psoriasis	1.77e-05	0.000218	CcSEcCtD
Indomethacin—Nausea—Dexamethasone—psoriasis	1.77e-05	0.000218	CcSEcCtD
Indomethacin—Nausea—Betamethasone—psoriasis	1.77e-05	0.000218	CcSEcCtD
Indomethacin—Urticaria—Methotrexate—psoriasis	1.72e-05	0.000212	CcSEcCtD
Indomethacin—Dizziness—Prednisone—psoriasis	1.72e-05	0.000211	CcSEcCtD
Indomethacin—Abdominal pain—Methotrexate—psoriasis	1.72e-05	0.000211	CcSEcCtD
Indomethacin—Body temperature increased—Methotrexate—psoriasis	1.72e-05	0.000211	CcSEcCtD
Indomethacin—Vomiting—Prednisone—psoriasis	1.65e-05	0.000203	CcSEcCtD
Indomethacin—Rash—Prednisone—psoriasis	1.64e-05	0.000201	CcSEcCtD
Indomethacin—Dermatitis—Prednisone—psoriasis	1.64e-05	0.000201	CcSEcCtD
Indomethacin—Headache—Prednisone—psoriasis	1.63e-05	0.0002	CcSEcCtD
Indomethacin—Hypersensitivity—Methotrexate—psoriasis	1.6e-05	0.000196	CcSEcCtD
Indomethacin—Asthenia—Methotrexate—psoriasis	1.56e-05	0.000191	CcSEcCtD
Indomethacin—Nausea—Prednisone—psoriasis	1.54e-05	0.000189	CcSEcCtD
Indomethacin—Pruritus—Methotrexate—psoriasis	1.54e-05	0.000189	CcSEcCtD
Indomethacin—ALB—Selenium Micronutrient Network—IFNG—psoriasis	1.5e-05	0.000444	CbGpPWpGaD
Indomethacin—PPARG—Circadian rythm related genes—JUN—psoriasis	1.49e-05	0.000441	CbGpPWpGaD
Indomethacin—Diarrhoea—Methotrexate—psoriasis	1.48e-05	0.000182	CcSEcCtD
Indomethacin—AKR1C3—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.47e-05	0.000435	CbGpPWpGaD
Indomethacin—PTGS2—Spinal Cord Injury—IFNG—psoriasis	1.47e-05	0.000434	CbGpPWpGaD
Indomethacin—CXCL8—Cellular responses to stress—NFKB1—psoriasis	1.47e-05	0.000433	CbGpPWpGaD
Indomethacin—PPARA—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.47e-05	0.000433	CbGpPWpGaD
Indomethacin—ABCB1—Allograft Rejection—IFNG—psoriasis	1.44e-05	0.000424	CbGpPWpGaD
Indomethacin—Dizziness—Methotrexate—psoriasis	1.43e-05	0.000176	CcSEcCtD
Indomethacin—PTGDR2—Signaling by GPCR—CXCL8—psoriasis	1.43e-05	0.000423	CbGpPWpGaD
Indomethacin—ABCB1—HIF-1-alpha transcription factor network—JUN—psoriasis	1.43e-05	0.000423	CbGpPWpGaD
Indomethacin—PPARA—Developmental Biology—PPARG—psoriasis	1.43e-05	0.000422	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—CYP2S1—psoriasis	1.4e-05	0.000415	CbGpPWpGaD
Indomethacin—CXCL8—SIDS Susceptibility Pathways—IL6—psoriasis	1.4e-05	0.000414	CbGpPWpGaD
Indomethacin—Vomiting—Methotrexate—psoriasis	1.38e-05	0.000169	CcSEcCtD
Indomethacin—PPARA—Circadian rythm related genes—TP53—psoriasis	1.37e-05	0.000406	CbGpPWpGaD
Indomethacin—Rash—Methotrexate—psoriasis	1.37e-05	0.000168	CcSEcCtD
Indomethacin—PTGS2—Spinal Cord Injury—CXCL8—psoriasis	1.37e-05	0.000403	CbGpPWpGaD
Indomethacin—Dermatitis—Methotrexate—psoriasis	1.37e-05	0.000168	CcSEcCtD
Indomethacin—PPARA—Metabolism—CARM1—psoriasis	1.37e-05	0.000403	CbGpPWpGaD
Indomethacin—Headache—Methotrexate—psoriasis	1.36e-05	0.000167	CcSEcCtD
Indomethacin—ABCB1—Allograft Rejection—CXCL8—psoriasis	1.34e-05	0.000394	CbGpPWpGaD
Indomethacin—CXCL8—Cellular responses to stress—VEGFA—psoriasis	1.33e-05	0.000393	CbGpPWpGaD
Indomethacin—CXCL8—Cellular Senescence—TP53—psoriasis	1.33e-05	0.000393	CbGpPWpGaD
Indomethacin—PLA2G2A—Metabolism—CAT—psoriasis	1.33e-05	0.000391	CbGpPWpGaD
Indomethacin—CXCL8—Cellular responses to stress—STAT3—psoriasis	1.32e-05	0.000389	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—NDUFA5—psoriasis	1.31e-05	0.000387	CbGpPWpGaD
Indomethacin—PTGS2—Integrated Pancreatic Cancer Pathway—NFKBIA—psoriasis	1.3e-05	0.000385	CbGpPWpGaD
Indomethacin—Nausea—Methotrexate—psoriasis	1.29e-05	0.000158	CcSEcCtD
Indomethacin—PPARG—Adipogenesis—IL6—psoriasis	1.28e-05	0.000377	CbGpPWpGaD
Indomethacin—PPARA—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.28e-05	0.000377	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling Pathways—LEP—psoriasis	1.28e-05	0.000376	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling Pathways—APOE—psoriasis	1.28e-05	0.000376	CbGpPWpGaD
Indomethacin—PPARG—Gene Expression—CARM1—psoriasis	1.26e-05	0.000372	CbGpPWpGaD
Indomethacin—PPARA—Circadian rythm related genes—IL6—psoriasis	1.26e-05	0.000371	CbGpPWpGaD
Indomethacin—PPARA—Developmental Biology—TYK2—psoriasis	1.25e-05	0.00037	CbGpPWpGaD
Indomethacin—ABCB1—HIF-1-alpha transcription factor network—VEGFA—psoriasis	1.25e-05	0.00037	CbGpPWpGaD
Indomethacin—ALB—Selenium Micronutrient Network—NFKB1—psoriasis	1.25e-05	0.000369	CbGpPWpGaD
Indomethacin—ALB—Platelet degranulation—VEGFA—psoriasis	1.23e-05	0.000362	CbGpPWpGaD
Indomethacin—ALB—Folate Metabolism—TNF—psoriasis	1.23e-05	0.000362	CbGpPWpGaD
Indomethacin—PTGS1—Selenium Micronutrient Network—IL6—psoriasis	1.22e-05	0.000361	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism of lipids and lipoproteins—CARM1—psoriasis	1.22e-05	0.000361	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—CCL20—psoriasis	1.22e-05	0.000361	CbGpPWpGaD
Indomethacin—CXCL8—Cellular Senescence—IL6—psoriasis	1.22e-05	0.00036	CbGpPWpGaD
Indomethacin—ALB—Vitamin B12 Metabolism—IL6—psoriasis	1.22e-05	0.000359	CbGpPWpGaD
Indomethacin—PTGS2—Selenium Micronutrient Network—TNF—psoriasis	1.2e-05	0.000355	CbGpPWpGaD
Indomethacin—ABCC4—Platelet activation, signaling and aggregation—VEGFA—psoriasis	1.2e-05	0.000355	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling Pathways—NFKBIA—psoriasis	1.19e-05	0.000351	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—ITGAL—psoriasis	1.18e-05	0.000348	CbGpPWpGaD
Indomethacin—PPARG—Developmental Biology—LEP—psoriasis	1.18e-05	0.000347	CbGpPWpGaD
Indomethacin—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—psoriasis	1.17e-05	0.000345	CbGpPWpGaD
Indomethacin—CXCL8—Metabolism of proteins—LEP—psoriasis	1.15e-05	0.00034	CbGpPWpGaD
Indomethacin—SLC10A1—Metabolism—CAT—psoriasis	1.13e-05	0.000333	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—CYP2S1—psoriasis	1.12e-05	0.000329	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.11e-05	0.000328	CbGpPWpGaD
Indomethacin—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—psoriasis	1.1e-05	0.000325	CbGpPWpGaD
Indomethacin—ABCB1—Allograft Rejection—VEGFA—psoriasis	1.09e-05	0.00032	CbGpPWpGaD
Indomethacin—ALB—Folate Metabolism—TP53—psoriasis	1.08e-05	0.000319	CbGpPWpGaD
Indomethacin—ABCC4—Hemostasis—NOS2—psoriasis	1.07e-05	0.000316	CbGpPWpGaD
Indomethacin—ALB—Metabolism—NDUFA5—psoriasis	1.06e-05	0.000313	CbGpPWpGaD
Indomethacin—PPARG—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.05e-05	0.00031	CbGpPWpGaD
Indomethacin—PPARA—Gene Expression—VDR—psoriasis	1.05e-05	0.00031	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism—CARM1—psoriasis	1.04e-05	0.000306	CbGpPWpGaD
Indomethacin—UGT2B7—Metabolism—CARM1—psoriasis	1.04e-05	0.000306	CbGpPWpGaD
Indomethacin—PLA2G2A—Metabolism—APOE—psoriasis	1.03e-05	0.000304	CbGpPWpGaD
Indomethacin—CXCL8—Cellular responses to stress—TP53—psoriasis	1.01e-05	0.000297	CbGpPWpGaD
Indomethacin—ALB—Metabolism of lipids and lipoproteins—CARM1—psoriasis	9.89e-06	0.000292	CbGpPWpGaD
Indomethacin—ALB—Folate Metabolism—IL6—psoriasis	9.89e-06	0.000292	CbGpPWpGaD
Indomethacin—ALB—Transmembrane transport of small molecules—CP—psoriasis	9.86e-06	0.000291	CbGpPWpGaD
Indomethacin—PPARG—Circadian rythm related genes—TP53—psoriasis	9.85e-06	0.000291	CbGpPWpGaD
Indomethacin—PPARG—Metabolism—CARM1—psoriasis	9.79e-06	0.000289	CbGpPWpGaD
Indomethacin—PPARA—Developmental Biology—NFKB1—psoriasis	9.76e-06	0.000288	CbGpPWpGaD
Indomethacin—ALB—Selenium Micronutrient Network—TNF—psoriasis	9.74e-06	0.000287	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling Pathways—TYK2—psoriasis	9.73e-06	0.000287	CbGpPWpGaD
Indomethacin—PTGS2—Selenium Micronutrient Network—IL6—psoriasis	9.71e-06	0.000287	CbGpPWpGaD
Indomethacin—AKR1C3—Metabolism—CAT—psoriasis	9.69e-06	0.000286	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism of lipids and lipoproteins—PPARG—psoriasis	9.68e-06	0.000286	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism of lipids and lipoproteins—APOE—psoriasis	9.68e-06	0.000286	CbGpPWpGaD
Indomethacin—AKR1C3—Disease—HLA-A—psoriasis	9.63e-06	0.000284	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—NDUFA5—psoriasis	9.53e-06	0.000281	CbGpPWpGaD
Indomethacin—PTGS2—Spinal Cord Injury—TNF—psoriasis	9.52e-06	0.000281	CbGpPWpGaD
Indomethacin—ALB—Transmembrane transport of small molecules—CARM1—psoriasis	9.41e-06	0.000278	CbGpPWpGaD
Indomethacin—ABCB1—Allograft Rejection—TNF—psoriasis	9.3e-06	0.000274	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—NDUFA5—psoriasis	9.3e-06	0.000274	CbGpPWpGaD
Indomethacin—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—psoriasis	9.24e-06	0.000273	CbGpPWpGaD
Indomethacin—CXCL8—Cellular responses to stress—IL6—psoriasis	9.21e-06	0.000272	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism of lipids and lipoproteins—APOE—psoriasis	9.03e-06	0.000267	CbGpPWpGaD
Indomethacin—ALB—Metabolism—CYP2S1—psoriasis	9.02e-06	0.000266	CbGpPWpGaD
Indomethacin—PPARG—Circadian rythm related genes—IL6—psoriasis	9.02e-06	0.000266	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—CARM1—psoriasis	9.02e-06	0.000266	CbGpPWpGaD
Indomethacin—AKR1C3—Disease—APOE—psoriasis	8.99e-06	0.000265	CbGpPWpGaD
Indomethacin—PPARG—Developmental Biology—TYK2—psoriasis	8.98e-06	0.000265	CbGpPWpGaD
Indomethacin—PLA2G2A—Metabolism—PPARG—psoriasis	8.97e-06	0.000265	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism of lipids and lipoproteins—CARM1—psoriasis	8.88e-06	0.000262	CbGpPWpGaD
Indomethacin—PPARA—Developmental Biology—VEGFA—psoriasis	8.86e-06	0.000262	CbGpPWpGaD
Indomethacin—PPARA—Developmental Biology—STAT3—psoriasis	8.78e-06	0.000259	CbGpPWpGaD
Indomethacin—SLC10A1—Metabolism—APOE—psoriasis	8.76e-06	0.000259	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism of lipids and lipoproteins—APOE—psoriasis	8.71e-06	0.000257	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—NDUFA5—psoriasis	8.69e-06	0.000256	CbGpPWpGaD
Indomethacin—PTGS2—Integrated Pancreatic Cancer Pathway—JUN—psoriasis	8.65e-06	0.000255	CbGpPWpGaD
Indomethacin—ABCB1—Transmembrane transport of small molecules—CP—psoriasis	8.64e-06	0.000255	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—SOCS1—psoriasis	8.53e-06	0.000252	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling Pathways—CXCL8—psoriasis	8.47e-06	0.00025	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism of lipids and lipoproteins—PPARG—psoriasis	8.43e-06	0.000249	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—CARM1—psoriasis	8.42e-06	0.000248	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—CARM1—psoriasis	8.42e-06	0.000248	CbGpPWpGaD
Indomethacin—PPARA—Metabolism—CAT—psoriasis	8.41e-06	0.000248	CbGpPWpGaD
Indomethacin—PTGS2—Spinal Cord Injury—TP53—psoriasis	8.39e-06	0.000248	CbGpPWpGaD
Indomethacin—AKR1C3—Disease—NOS2—psoriasis	8.38e-06	0.000247	CbGpPWpGaD
Indomethacin—PTGS2—Integrated Pancreatic Cancer Pathway—NFKB1—psoriasis	8.32e-06	0.000246	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism of lipids and lipoproteins—APOE—psoriasis	8.28e-06	0.000244	CbGpPWpGaD
Indomethacin—ABCB1—Transmembrane transport of small molecules—CARM1—psoriasis	8.24e-06	0.000243	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—CARM1—psoriasis	8.11e-06	0.000239	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—CYP2S1—psoriasis	8.1e-06	0.000239	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism of lipids and lipoproteins—CARM1—psoriasis	8.1e-06	0.000239	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling by GPCR—IL6—psoriasis	8.06e-06	0.000238	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—CYP2S1—psoriasis	7.91e-06	0.000233	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling Pathways—JUN—psoriasis	7.88e-06	0.000233	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism of lipids and lipoproteins—PPARG—psoriasis	7.87e-06	0.000232	CbGpPWpGaD
Indomethacin—ALB—Selenium Micronutrient Network—IL6—psoriasis	7.86e-06	0.000232	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—CARM1—psoriasis	7.71e-06	0.000228	CbGpPWpGaD
Indomethacin—PTGS2—Spinal Cord Injury—IL6—psoriasis	7.68e-06	0.000227	CbGpPWpGaD
Indomethacin—SLC10A1—Metabolism—PPARG—psoriasis	7.63e-06	0.000225	CbGpPWpGaD
Indomethacin—PPARA—Developmental Biology—TNF—psoriasis	7.6e-06	0.000224	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism of lipids and lipoproteins—PPARG—psoriasis	7.58e-06	0.000224	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling Pathways—NFKB1—psoriasis	7.58e-06	0.000224	CbGpPWpGaD
Indomethacin—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—psoriasis	7.55e-06	0.000223	CbGpPWpGaD
Indomethacin—AKR1C3—Metabolism—APOE—psoriasis	7.53e-06	0.000222	CbGpPWpGaD
Indomethacin—PPARG—Gene Expression—VDR—psoriasis	7.52e-06	0.000222	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—CYP2S1—psoriasis	7.38e-06	0.000218	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism of lipids and lipoproteins—APOE—psoriasis	7.36e-06	0.000217	CbGpPWpGaD
Indomethacin—PPARA—Gene Expression—PPARG—psoriasis	7.32e-06	0.000216	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism of lipids and lipoproteins—PPARG—psoriasis	7.21e-06	0.000213	CbGpPWpGaD
Indomethacin—PPARG—Developmental Biology—NFKB1—psoriasis	7e-06	0.000207	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling Pathways—VEGFA—psoriasis	6.88e-06	0.000203	CbGpPWpGaD
Indomethacin—AKR1C3—Disease—TYK2—psoriasis	6.86e-06	0.000203	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—CARM1—psoriasis	6.86e-06	0.000202	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling Pathways—STAT3—psoriasis	6.81e-06	0.000201	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—SOCS1—psoriasis	6.73e-06	0.000199	CbGpPWpGaD
Indomethacin—AKR1C3—Metabolism—PPARG—psoriasis	6.56e-06	0.000194	CbGpPWpGaD
Indomethacin—PPARA—Metabolism—APOE—psoriasis	6.53e-06	0.000193	CbGpPWpGaD
Indomethacin—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—psoriasis	6.47e-06	0.000191	CbGpPWpGaD
Indomethacin—CXCL8—Signaling by GPCR—TYK2—psoriasis	6.42e-06	0.000189	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism of lipids and lipoproteins—PPARG—psoriasis	6.41e-06	0.000189	CbGpPWpGaD
Indomethacin—UGT2B7—Metabolism—CAT—psoriasis	6.37e-06	0.000188	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism—CAT—psoriasis	6.37e-06	0.000188	CbGpPWpGaD
Indomethacin—PPARG—Developmental Biology—VEGFA—psoriasis	6.35e-06	0.000187	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—LEP—psoriasis	6.3e-06	0.000186	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—APOE—psoriasis	6.3e-06	0.000186	CbGpPWpGaD
Indomethacin—PPARG—Developmental Biology—STAT3—psoriasis	6.29e-06	0.000186	CbGpPWpGaD
Indomethacin—AKR1C3—Disease—CD4—psoriasis	6.21e-06	0.000183	CbGpPWpGaD
Indomethacin—ABCC4—Hemostasis—VEGFA—psoriasis	6.19e-06	0.000183	CbGpPWpGaD
Indomethacin—PPARA—Developmental Biology—IL6—psoriasis	6.13e-06	0.000181	CbGpPWpGaD
Indomethacin—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—psoriasis	6.13e-06	0.000181	CbGpPWpGaD
Indomethacin—PPARG—Metabolism—CAT—psoriasis	6.02e-06	0.000178	CbGpPWpGaD
Indomethacin—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—psoriasis	5.9e-06	0.000174	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—NFKBIA—psoriasis	5.87e-06	0.000173	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism of lipids and lipoproteins—APOE—psoriasis	5.84e-06	0.000172	CbGpPWpGaD
Indomethacin—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—psoriasis	5.71e-06	0.000168	CbGpPWpGaD
Indomethacin—PPARA—Metabolism—PPARG—psoriasis	5.69e-06	0.000168	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—CAT—psoriasis	5.55e-06	0.000164	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—CARM1—psoriasis	5.45e-06	0.000161	CbGpPWpGaD
Indomethacin—PPARG—Developmental Biology—TNF—psoriasis	5.44e-06	0.000161	CbGpPWpGaD
Indomethacin—ALB—Platelet activation, signaling and aggregation—VEGFA—psoriasis	5.44e-06	0.00016	CbGpPWpGaD
Indomethacin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—psoriasis	5.35e-06	0.000158	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling Pathways—TP53—psoriasis	5.2e-06	0.000153	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—CAT—psoriasis	5.18e-06	0.000153	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—CAT—psoriasis	5.18e-06	0.000153	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism of lipids and lipoproteins—PPARG—psoriasis	5.09e-06	0.00015	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—CAT—psoriasis	4.99e-06	0.000147	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—APOE—psoriasis	4.97e-06	0.000147	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—LEP—psoriasis	4.97e-06	0.000147	CbGpPWpGaD
Indomethacin—ABCC1—Disease—HLA-A—psoriasis	4.96e-06	0.000146	CbGpPWpGaD
Indomethacin—UGT2B7—Metabolism—APOE—psoriasis	4.95e-06	0.000146	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism—APOE—psoriasis	4.95e-06	0.000146	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—NOS2—psoriasis	4.84e-06	0.000143	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—TYK2—psoriasis	4.81e-06	0.000142	CbGpPWpGaD
Indomethacin—AKR1C3—Disease—STAT3—psoriasis	4.81e-06	0.000142	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling Pathways—IL6—psoriasis	4.76e-06	0.00014	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—CAT—psoriasis	4.74e-06	0.00014	CbGpPWpGaD
Indomethacin—ALB—Metabolism of lipids and lipoproteins—APOE—psoriasis	4.73e-06	0.00014	CbGpPWpGaD
Indomethacin—ABCC4—Hemostasis—TP53—psoriasis	4.68e-06	0.000138	CbGpPWpGaD
Indomethacin—PPARG—Metabolism—APOE—psoriasis	4.68e-06	0.000138	CbGpPWpGaD
Indomethacin—ABCC1—Disease—APOE—psoriasis	4.63e-06	0.000137	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—NFKBIA—psoriasis	4.63e-06	0.000137	CbGpPWpGaD
Indomethacin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—psoriasis	4.59e-06	0.000135	CbGpPWpGaD
Indomethacin—ALB—Metabolism—CARM1—psoriasis	4.41e-06	0.00013	CbGpPWpGaD
Indomethacin—PPARG—Developmental Biology—IL6—psoriasis	4.39e-06	0.00013	CbGpPWpGaD
Indomethacin—ABCC1—Disease—NOS2—psoriasis	4.32e-06	0.000127	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism—PPARG—psoriasis	4.31e-06	0.000127	CbGpPWpGaD
Indomethacin—UGT2B7—Metabolism—PPARG—psoriasis	4.31e-06	0.000127	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—APOE—psoriasis	4.31e-06	0.000127	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism of lipids and lipoproteins—APOE—psoriasis	4.24e-06	0.000125	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—CAT—psoriasis	4.22e-06	0.000125	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—CXCL8—psoriasis	4.19e-06	0.000124	CbGpPWpGaD
Indomethacin—ALB—Metabolism of lipids and lipoproteins—PPARG—psoriasis	4.12e-06	0.000122	CbGpPWpGaD
Indomethacin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—psoriasis	4.05e-06	0.000119	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—APOE—psoriasis	4.02e-06	0.000119	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—APOE—psoriasis	4.02e-06	0.000119	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—CARM1—psoriasis	3.96e-06	0.000117	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—JUN—psoriasis	3.89e-06	0.000115	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—APOE—psoriasis	3.88e-06	0.000114	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism of lipids and lipoproteins—APOE—psoriasis	3.87e-06	0.000114	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—CARM1—psoriasis	3.86e-06	0.000114	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—TYK2—psoriasis	3.79e-06	0.000112	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—PPARG—psoriasis	3.75e-06	0.000111	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—NFKB1—psoriasis	3.75e-06	0.000111	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—psoriasis	3.7e-06	0.000109	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—APOE—psoriasis	3.69e-06	0.000109	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—CARM1—psoriasis	3.61e-06	0.000106	CbGpPWpGaD
Indomethacin—ABCC1—Disease—TYK2—psoriasis	3.53e-06	0.000104	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—PPARG—psoriasis	3.5e-06	0.000103	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—PPARG—psoriasis	3.5e-06	0.000103	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—VEGFA—psoriasis	3.4e-06	0.0001	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—PPARG—psoriasis	3.38e-06	9.97e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—psoriasis	3.37e-06	9.95e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—STAT3—psoriasis	3.37e-06	9.93e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Disease—IL6—psoriasis	3.36e-06	9.91e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—CAT—psoriasis	3.35e-06	9.89e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—HLA-A—psoriasis	3.33e-06	9.82e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—APOE—psoriasis	3.28e-06	9.68e-05	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—PPARG—psoriasis	3.21e-06	9.47e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—CD4—psoriasis	3.2e-06	9.43e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling by GPCR—IL6—psoriasis	3.14e-06	9.27e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—APOE—psoriasis	3.11e-06	9.17e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—JUN—psoriasis	3.07e-06	9.06e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—NFKB1—psoriasis	2.95e-06	8.72e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—NOS2—psoriasis	2.9e-06	8.55e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—PPARG—psoriasis	2.86e-06	8.43e-05	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—VEGFA—psoriasis	2.8e-06	8.27e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—CAT—psoriasis	2.71e-06	8e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—VEGFA—psoriasis	2.68e-06	7.91e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—STAT3—psoriasis	2.66e-06	7.84e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—APOE—psoriasis	2.6e-06	7.68e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—TP53—psoriasis	2.57e-06	7.58e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—STAT3—psoriasis	2.47e-06	7.3e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—CAT—psoriasis	2.43e-06	7.18e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—CAT—psoriasis	2.37e-06	7.01e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—TYK2—psoriasis	2.37e-06	7e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—IL6—psoriasis	2.35e-06	6.94e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—PPARG—psoriasis	2.27e-06	6.69e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—CAT—psoriasis	2.22e-06	6.55e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—CD4—psoriasis	2.15e-06	6.33e-05	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—TP53—psoriasis	2.12e-06	6.25e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—APOE—psoriasis	2.11e-06	6.21e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—TP53—psoriasis	2.03e-06	5.98e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—APOE—psoriasis	1.89e-06	5.58e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—IL6—psoriasis	1.85e-06	5.47e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—APOE—psoriasis	1.84e-06	5.44e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—PPARG—psoriasis	1.83e-06	5.41e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—IL6—psoriasis	1.73e-06	5.1e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—APOE—psoriasis	1.72e-06	5.09e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—STAT3—psoriasis	1.66e-06	4.9e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—PPARG—psoriasis	1.65e-06	4.86e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—PPARG—psoriasis	1.61e-06	4.74e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—PPARG—psoriasis	1.5e-06	4.43e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—IL6—psoriasis	1.16e-06	3.42e-05	CbGpPWpGaD
